Data / Form D filings / DIVERSE BIOTECH, INC.
DIVERSE BIOTECH, INC.: Form D filings
DIVERSE BIOTECH, INC., a pharmaceuticals company in Miami, FL, filed 4 Form D notices with the SEC between 2018 and 2023. The latest, on March 10, 2023, reports an offering of $950,000 with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1951 NW 7th Ave, Suite 600, Miami, FL, 33136
- Phone
- (267) 899-0065
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1744231
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | New notice | $950,000 | $0 | $950,000 | 0 | Yet to occur | sec.gov |
| Sep 4, 2019 | Amendment | $8,997,723 | $337,869 | $8,659,854 | 1 | Mar 12, 2019 | sec.gov |
| Dec 6, 2018 | New notice | $8,997,723 | $0 | $8,997,723 | 0 | Yet to occur | sec.gov |
| Jun 21, 2018 | New notice | $7,500,000 | $669,000 | $6,831,000 | 1 | Jun 19, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JOHN PATRICK | Director | |
| Phillip Haretos | Director | |
| WILLIAM FISHER | Executive Officer, Director, Promoter | |
| PHILIP ARLEN | Director | |
| Phyllis Fenney | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DIVERSE BIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.